Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice - Wikidata - wikimedia - TriplyDB

Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice

Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice

http://www.wikidata.org/entity/Q34013102

about

Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.An Update on CRF Mechanisms Underlying Alcohol Use Disorders and Dependence Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.The role of CRF and CRF-related peptides in the dark side of addiction.Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference.Methamphetamine drinking microstructure in mice bred to drink high or low amounts of methamphetamine Corticotropin releasing factor: a key role in the neurobiology of addiction Increased alcohol consumption in urocortin 3 knockout mice is unaffected by chronic inflammatory pain.Ethanol produces corticotropin-releasing factor receptor-dependent enhancement of spontaneous glutamatergic transmission in the mouse central amygdala Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.Alcohol in excess: CRF₁ receptors in the rat and mouse VTA and DRN.Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area.Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.Corticotropin-releasing factor: innocent until proven guilty.Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders.Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?Centrally administered urocortin 3 inhibits food intake and gastric emptying in mice.

P2860

Q27011274-2F019EC2-8B24-4580-A73D-60B490892912 Q28069782-DCECBE84-AE43-4E8D-9197-AB62A2DEF41E Q30468942-EFF7603D-810D-465A-BF9D-F917DD97213D Q30476985-496E0D4B-613A-4588-813E-D0ED1CA75D1E Q33553871-FB9546D0-54BE-405E-AA56-BEB3130D6550 Q34064888-868867BE-4706-44F4-80BD-59A5ED6AEC80 Q34204281-80046158-AD08-4395-A922-2236EFCE9EB4 Q34421204-802BD46E-7CA8-4DCF-A474-306A2B94526B Q35081542-31DCACF2-77BB-441C-A2B8-20152F9BE850 Q36218971-3F063859-DDB1-4CC9-AE9B-49B417E8C218 Q36390400-736952BC-B14C-4F77-9500-63F8A1047E77 Q36456879-C4D2751D-E9DD-4BCA-857C-C655D518BD1E Q36852840-804940FA-805D-418E-BB1B-9B09A8EB922E Q37700982-4C159E00-DE19-466E-A9F4-7A80188B408D Q37702334-4FFE594B-0114-4914-B1B9-6125119DE208 Q43187521-2880C06F-DD4F-4E97-A4FA-A3DC04D531C2 Q46519736-09AAA36D-1D2D-48E7-A3B0-37723C89978F Q48008300-9DCBAA9C-D699-4E1D-AD30-F646EFE5DB6B Q48305886-ED88489D-142F-48B2-B1B3-142AF42431DB Q51387191-FD0DDDB3-57A1-48A2-AB78-396D43573205

P2860

Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice

http://www.wikidata.org/entity/Q34013102

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Central urocortin 3 administra ...... ol intake in nondependent mice

@ast

Central urocortin 3 administra ...... ol intake in nondependent mice

@en

Central urocortin 3 administra ...... ol intake in nondependent mice

@nl

type

label

Central urocortin 3 administra ...... ol intake in nondependent mice

@ast

Central urocortin 3 administra ...... ol intake in nondependent mice

@en

Central urocortin 3 administra ...... ol intake in nondependent mice

@nl

prefLabel

Central urocortin 3 administra ...... ol intake in nondependent mice

@ast

Central urocortin 3 administra ...... ol intake in nondependent mice

@en

Central urocortin 3 administra ...... ol intake in nondependent mice

@nl

P1433

Q34013102-F14B1F80-665E-490F-A47F-C0E8027C2A60

P1476

Q34013102-37AD519C-2480-4CE2-9BF3-E854C0243A80

P2093

Q34013102-0EEB784F-D4EF-4702-B322-02077C55E65E

Q34013102-97CE4097-1D3A-4826-BC06-2148D44B99D1

P2860

Q34013102-01CE354A-F42D-430E-AE59-F2CFD5603E2B

Q34013102-087F4273-63F6-4AAA-B3DB-5CB10935E1EF

Q34013102-0B882DA2-7E8C-4EEF-9F4E-243961A3A84B

Q34013102-1FA1A914-0104-4A59-86B5-4EA1AAF4E1CB

Q34013102-2FE5AE9D-AE52-451B-845C-2B22293BE848

Q34013102-30B622A9-9794-4D5B-AA92-B8760AABB23D

Q34013102-321AA64F-ECBA-478D-8215-2094F83DE0C3

Q34013102-36597284-17D3-4EC8-9500-D1F48F17F519

Q34013102-3E2A6416-4577-4B41-8AFA-B64A93A8B391

Q34013102-4CF6D035-BADA-4DF1-B635-56DD9B53D489

P304

Q34013102-9B3C4FE8-A6B5-47DF-894B-E4F863E2F2AC

P31

Q34013102-8D5E88CB-0755-4334-83E5-CB560AA77EDD

P356

Q34013102-318D59E8-8419-4E8E-96E2-19EFB86D43E7

P433

Q34013102-0820D967-4972-4EF9-8871-D450B495BBFF

P478

Q34013102-8CAD97D8-7F5A-4FCA-8CCE-3F569BB50873

P577

Q34013102-6B97190F-68C3-4854-869D-EC1316DCB1BA

P698

Q34013102-20AC2CCA-4D94-46E4-9BE5-1B2D880681E5

P932

Q34013102-13391F44-699A-4A7E-9F30-EAEBB898745F

P356

FBP.0B013E32832F01BA

P1433

Behavioural Pharmacology

P1476

Central urocortin 3 administra ...... ol intake in nondependent mice

@en

P2093

Amanda L Sharpe

http://www.w3.org/2001/XMLSchema#string

Tamara J Phillips

http://www.w3.org/2001/XMLSchema#string

P2860

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids

Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression

A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats.

Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption

A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress.

P304

346-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FBP.0B013E32832F01BA

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19581799

http://www.w3.org/2001/XMLSchema#string

P932

2908376

http://www.w3.org/2001/XMLSchema#string